Home › Refractory Anemia na May Sobrang Blasts › Maryland
Pag-aaral pangklinika para sa Refractory Anemia na May Sobrang Blasts sa Maryland
3 pag-aaral para sa Refractory Anemia na May Sobrang Blasts ang naghahanap ng mga kalahok sa mga site sa Maryland.
Opisyal na teksto ng pag-aaral (English)
Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations
- National Institutes of Health Clinical Center, Bethesda
Nagre-recruitPhase 2
Edad 6 hanggang 70 · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT01861106Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms
- National Institutes of Health Clinical Center, Bethesda
Nagre-recruitPhase 1/2
Edad 12 hanggang 120 · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT06303193Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- National Institutes of Health Clinical Center, Bethesda
Nagre-recruitPhase 2
Edad 4 hanggang 80 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT01174108Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.